BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dentons ventureBeyond - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.dentonsventurebeyond.com
X-WR-CALDESC:Events for Dentons ventureBeyond
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251008T130000
DTEND;TZID=America/New_York:20251008T140000
DTSTAMP:20260406T015756
CREATED:20250929T191412Z
LAST-MODIFIED:20250929T191443Z
UID:5644-1759928400-1759932000@www.dentonsventurebeyond.com
SUMMARY:Capital at the Crossroads: Navigating Today’s Life Sciences Market Realities with ThinkEquity and Nasdaq
DESCRIPTION:Dentons is launching a new roundtable series for biotech\, pharma and med device leaders—bringing market experts and investors together to share clear perspectives on today’s capital markets\, from current challenges to emerging opportunities. \nEpisode 1: State of the Markets \nOur first session will spotlight the realities of today’s financing and deal-making climate. Hear directly from Tara Sharif\, PhD\, MBA\, Managing Director at ThinkEquity and Andy Hall\, Senior Managing Director at Nasdaq as they share perspectives on where the markets stand\, what’s moving the needle and what companies should be preparing for in the year ahead. \nGuiding the conversation will be Dentons’ own Ira Kotel and Rob Condon\, who bring decades of experience at the intersection of life sciences and capital markets. Together\, they’ll frame the discussion around practical insights for companies considering fundraising\, public listings or strategic transactions. \nKey topics include: \n\nCurrent fundraising conditions and how they are reshaping biotech\, pharma and med device strategies.\nIPO and follow-on market activity—what it takes to go public in today’s climate.\nM&A and partnership trends\, including what acquirers and investors are looking for.
URL:https://www.dentonsventurebeyond.com/event/capital-at-the-crossroads-navigating-todays-life-sciences-market-realities-with-thinkequity-and-nasdaq/
END:VEVENT
END:VCALENDAR